ADRIAMYCIN (DOXORUBICIN) CARDIOTOXICITY: A REVIEWCHLEBOWSKI RT.1979; WEST. J. MED.; ISSN 0093-0415; USA; DA. 1979; VOL. 131; NO 5; PP. 364-368; BIBL. 43 REF.Article

ABNORMALITIES IN GLUCOSE AND PROTEIN METABOLISM IN NONCACHECTIC LUNG CANCER PATIENTSHEBER D; CHLEBOWSKI RT; ISHIBASHI DE et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 11; PP. 4815-4819; BIBL. 26 REF.Article

TREATMENT OF ADVANCED GASTRIC CARCINOMA WITH 5-FLUOROURACIL: A RANDOMIZED COMPARISON OF TWO ROUTES OF DELIVERYCHLEBOWSKI RT; PAROLY WS; PUGH RP et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1979-1981; BIBL. 10 REF.Article

TREATMENT OF ADVANCED BREAST CARCINOMA WITH 5-FLUOROURACIL. A RANDOMIZED COMPARISON OF TWO ROUTES OF DELIEVERYCHLEBOWSKI RT; PUGH RP; WEINER JM et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 8; PP. 1711-1714; BIBL. 18 REF.Article

CYCLOPHOSPHAMIDE (NSC 26271) VERSUS THE COMBINATION OF ADRIAMYCIN (NSC 123127), 5 FLUOROURACIL (NSC 19893), AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF METASTATIC PROSTATIC CANCER: A RANDOMIZED TRIALCHLEBOWSKI RT; HESTORFF R; SARDOFF L et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 6; PP. 2546-2552; BIBL. 8 REF.Article

RANDOMIZED COMPARISON OF TWO COMBINATION CHEMOTHERAPY REGIMENS CONTAINING DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST CANCER: A WESTERN CANCER STUDY GROUP TRIALIRWIN LE; CHLEBOWSKI RT; WEINER JM et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 8-9; PP. 981-984; BIBL. 11 REF.Article

CLINICAL AND PHARMACOKINETIC EFFECTS OF COMBINED WARFARIN AND 5-FLUOROURACIL IN ADVANCED COLON CANCERCHLEBOWSKI RT; GOTA CH; CHAN KK et al.1982; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 11; PP. 4827-4830; BIBL. 23 REF.Article

DOSIMETRY AND PRELIMINARY HUMAN STUDIES OF ¹⁸F-5-FLUOROURACILSHANI J; YOUNG D; SCHLESINGER T et al.1982; INT. J. NUCL. MED. BIOL.; ISSN 0047-0740; USA; DA. 1982; VOL. 9; NO 1; PP. 25-35; BIBL. 12 REF.Article

SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER TREATED WITH EITHER COMBINATION OR SEQUENTIAL CHEMOTHERAPY: A WESTERN CANCER STUDY GROUP PROJECTCHLEBOWSKI RT; IRWIN LE; PUGH RP et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 11; PP. 4503-4506; BIBL. 14 REF.Article

TREATMENT OF ADVANCED COLON CANCER WITH 5-FLUOROURACIL (NSC 19893) VERSUS CYCLOPHOSPHAMIDE (NSC 26271) PLUS 5-FLUOROURACIL: PROGNOSTIC ASPECTS OF THE DIFFERENTIAL WHITE BLOOD CELL COUNTCHLEBOWSKI RT; SILVERBERG I; PAJAK T et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 9; PP. 2240-2244; BIBL. 23 REF.Article

ADRIAMYCIN AND METHYL-CCNU COMBINATION THERAPY IN HEPATOCELLULAR CARCINOMA: CLINICAL AND PHARMACOKINETIC ASPECTSCHLEBOWSKI RT; CHAN KK; TONG MJ et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 5; PP. 1088-1095; BIBL. 32 REF.Article

METABOLISM OF METHOTREXATE IN MAN AFTER HIGH AND CONVENTIONAL DOSESCHAN KK; BALACHANDRAN NAYAR MS; COHEN JL et al.1980; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1980; VOL. 28; NO 3; PP. 551-561; BIBL. 2 P.Article

SIGNIFICANCE OF RELAPSE AFTER ADJUVANT TREATMENT WITH COMBINATION CHEMOTHERAPY OR 5-FLUOROURACIL ALONE IN HIGH-RISK BREAST CANCERCHLEBOWSKI RT; WEINER JM; LUCE J et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 11; PART. 1; PP. 4399-4403; BIBL. 22 REF.Article